Welcome to chemicalbook!
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook > Product Catalogue >Biochemical Engineering >Polypeptide >ANP 1-28, HUMAN

ANP 1-28, HUMAN

ANP 1-28, HUMAN Structure
  • ₹0
  • Product name: ANP 1-28, HUMAN
  • CAS: 89213-87-6
  • MF: C127H203N45O39S3
  • MW: 3080.44
  • EINECS:686-482-9
  • MDL Number:MFCD00076226
  • Synonyms:Atrial natriureticpeptide-28 (huMan) (9CI);Atrial Natriuretic Factor (1-28) (huMan) αhANF, Carperitide;Carperitide Acetate;ATRIAL NATRIURETIC PEPTIDE HUMAN, 1-28;ATRIAL NATRIURETIC PEPTIDE 1-28, HUMAN;ATRIAL NATRIURETIC PEPTIDE (1-28), HUMAN, PORCINE;ATRIAL NATRIURETIC FACTOR 1-28, HUMAN;ATRIAL NATRIURETIC FACTOR (1-28) (HUMAN, CANINE)
Manufacturer Product number Product description Packaging Price Updated Buy

Properties

Density :1.55±0.1 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :Water: 1 mg/ml
form :A lyophilized powder
Sequence :H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH,(Disulfide bridge: Cys-Cys)

Safety Information

Symbol(GHS): GHS hazard pictograms
Signal word: Warning
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
H361 Suspected of damaging fertility or the unborn child Reproductive toxicity Category 2 Warning P201, P202, P281, P308+P313, P405,P501
Precautionary statements:
P201 Obtain special instructions before use.
P202 Do not handle until all safety precautions have been read and understood.
P281 Use personal protective equipment as required.
P308+P313 IF exposed or concerned: Get medical advice/attention.
P405 Store locked up.
P501 Dispose of contents/container to..…

Description

Carperitide is the α-human atrial natriuretic peptide (α-hANP) produced by recombinant technology. It was introduced in Japan as a treatment for acute congestive heart failure (CHF). In dogs with CHF, carperitide significantly reduced the elevated left ventricular end-diastolic pressure and the index of myocardial oxygen consumption (systolic blood pressure x heart rate). In a clinical trial, carperitide was effective in improving hemodynamics and symptoms in 60% of patients with acute CHF. Carperitide was reported to be well tolerated with no significant adverse effects clinically. A beneficial effect on hemodynamics has been reported in chronic heart failure patients. Carperitide is also in clinical trials for maintenance of blood pressure during surgical operations.

More related product prices

PENTAETHYLENEHEXAMINE

Related product price